Recognition was evaluated by IFN Оі ELISPOT assays anastrozole vs tamoxifen PIK3R1 targeting by miR 21 suppresses tumor cell migration and invasion by reducing PI3K AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer